...
首页> 外文期刊>Journal of Medicinal Chemistry >Inhibition of monoamine oxidase-B by condensed pyridazines and pyrimidines: effects of lipophilicity and structure-activity relationships.
【24h】

Inhibition of monoamine oxidase-B by condensed pyridazines and pyrimidines: effects of lipophilicity and structure-activity relationships.

机译:缩合的哒嗪和嘧啶对单胺氧化酶-B的抑制作用:亲脂性和构效关系的影响。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

A number of condensed pyridazines and pyrimidines were synthesized and tested for their monoamine oxidase-A (MAO-A) and MAO-B inhibitory activity. Their lipophilicity was examined by measuring partition coefficients and RP-HPLC capacity factors, revealing some peculiar electronic and conformational effects. Further insights were obtained by X-ray crystallography and a thermodynamic study of RP-HPLC retention. Structure-activity relations highlighted the main factors determining both selectivity and inhibitory potency. Thus, while most of the condensed pyridazines were reversible inhibitors of MAO-B with little or no MAO-A effects, the pyrimidine derivatives proved to be reversible and selective MAO-A inhibitors. Substituents on the diazine nucleus modulated enzyme inhibition. A QSAR analysis of X-substituted 3-X-phenyl-5H-indeno[1,2-c]pyridazin-5-ones showed lipophilicity to increase MAO-B and not MAO-A inhibitory activity.
机译:合成了许多缩合的哒嗪和嘧啶,并测试了它们的单胺氧化酶-A(MAO-A)和MAO-B抑制活性。通过测量分配系数和RP-HPLC容量因子检查了它们的亲脂性,发现了一些特殊的电子和构象效应。通过X射线晶体学和RP-HPLC保留的热力学研究获得了进一步的见解。构效关系突出了决定选择性和抑制效能的主要因素。因此,尽管大多数缩合的哒嗪是可逆的MAO-B抑制剂,几乎没有或没有MAO-A作用,但嘧啶衍生物被证明是可逆的和选择性的MAO-A抑制剂。取代基对二嗪核的酶抑制作用。 X-取代的3-X-苯基-5H-茚并[1,2-c]哒嗪-5-酮的QSAR分析显示亲脂性增加了MAO-B的活性,而不是增加了MAO-A的抑制活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号